Recombinant anti-plasmodium falciparum antibodies
CA 2458890 C · Owner: Druilhe, Pierre · Inventors: Druilhe, Pierre; Lundquist, Rasmus; Dziegiel, Morten Steen Hanefeld
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a recombinant human antibody comprising an antibodysequence specific for the MSP-3 antigen ofPlasmodium falciparum. In particular, theinvention relates to a recombinant human antibody which is specific for the MSP-3194-257 antigen. The invention further relates to nucleic acid encoding suchantibodies and to uses of these antibodies in , particular in the treatment or prophylaxisof malaria.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 16, 2002 and granted December 16, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 16, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 16, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.